Case Reports

Thyroid nodule: not as clear-cut as it seems


 

Benign etiologies and primary thyroid cancers are the most common causes of incidental thyroid nodules. Clinically evident metastases to the thyroid gland are not common and account for 2%-3% of thyroid cancers, though the incidence of thyroid metastases reaches 24% in autopsy studies.1 The most common clinically detected thyroid metastases originate from renal cell carcinoma (RCC; 48.1%).2 We report here a rare case of a man with clear-cell RCC with late recurrence in the thyroid gland as a solitary metastasis, 13 years after the primary diagnosis.

Click on the PDF icon at the top of this introduction to read the full article.

Recommended Reading

Percutaneous ethanol effective for small papillary thyroid cancers
MDedge Hematology and Oncology
Increased surveillance may explain post-Fukushima pediatric thyroid cancers
MDedge Hematology and Oncology
ASTRO: Less intense chemoradiation may be possible for HPV-related oropharyngeal cancers
MDedge Hematology and Oncology
ITC: Study provides first evidence of paclitaxel benefit for anaplastic thyroid cancer
MDedge Hematology and Oncology
Adjuvant lapatinib added no benefit against head and neck squamous cell carcinoma
MDedge Hematology and Oncology
Experimental LOXO-101 induces regression in several hard-to-treat cancers
MDedge Hematology and Oncology
Suicide rate high in patients with head and neck cancer
MDedge Hematology and Oncology
Balancing clinical and supportive care at every step of the disease continuum
MDedge Hematology and Oncology
Treatment delay linked with worse outcome for head and neck cancer
MDedge Hematology and Oncology
Oncology 2015: new therapies and new transitions toward value-based cancer care
MDedge Hematology and Oncology